Saturday, May 18
|
7:15 a.m. |
Continental Breakfast – Posters Available |
8 a.m. |
Welcome from the ATS President
- M. Patricia Rivera, MD, ATSF- Chief, Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center
|
8:10 a.m. |
Co-Chair Address: State of Innovation and Investment
- Sarah Spencer – Principal, EcoR1
- Tim Watkins, MD, MS – Vice President, Clinical Development; Head – Fibrosis & Pulmonary Diseases - Inflammation Therapeutics, Gilead Sciences
|
8:30 a.m. |
Showcase One: Asthma and COPD Innovators
- RaeSedo, Inc. – Monica Kraft, MD, Co-Founder
- RAGE Biotech – Gary Anderson, Advisor, Clinical Translation
- Realta LifeSciences – Neel Krishna, PhD
- Shanghi Novamab Biopharmaceuticals Co., LTD – Yakun Wan, PhD, Founder and CEO
- SMS Biotech – Abdulkader Rahmo, PhD – President and CSO
|
9 a.m. |
Panel: Investor Discussion
- Moderator: Brian Matesic, Principal at Norwest Venture Partners
- Niall O'Donnell, PhD - Managing Director, Rivervest
- Bernard Davitian, MSc, CPA, MBA – Partner, Omega Funds
- Drew Field – Vice President, Bain Capital Life Sciences
- Katarina Pance, PhD - Associate, SR One Capital Management
- Geeta Vemuri – Managing Partner / Founder, Agent Capital
|
9:45 a.m. |
Networking Break – Posters Available |
10:15 a.m. |
Showcase Two: COVID, Infectious Disease and Other Innovators
- Cystetic Medicines, Inc. – Martin D. Burke, MD, PhD – Co-Founder
- ENA Respiratory – Ruth Tal-Singer, PhD, Medicine Development Leader
- ReCode Therapeutics – John Matthews, MB, BS, PhD, MCRP – Chief Medical Officer
- RNATICS – Klaus Rabe, MD, Chief Medical Officer
- Vast Therapeutics – Nathan Stasko, PhD, MS, Chief Executive Officer
|
10:45 a.m. |
Fireside Chat: Accelerating Respiratory Discovery
- Moderator: Ted Reiss, MD, MBE, ATSF
- Sally Seymour, MD – Director, Division of Pulmonology, Allergy, and Critical Care, US Food and Drug Administration
- Banu Karimi-Shah, MD – Deputy Director, Division of Pulmonology, Allergy, Critical Care, US Food and Drug Administration
|
11:30 a.m. |
Showcase Three: Critical Care Innovators
- Atelerix Life Sciences – Benjamin Gaston, MD, Founder
- Chrysalis BioTherapeutics, Inc. – Darrell H. Carney, PhD, President and CEO
- Eldec Pharmaceuticals – Saira Ahmad, PhD, Director of Research
- Gen1E Lifesciences, Inc. – Ritu Lal, PhD, MS, Co-Founder and CEO
- Globin Solutions, Inc. – Jason Rose, MD, MBA, President & CEO
- Vasomune Therapeutics, Inc. – Harold Kim, PhD, Vice President, Research and Scientific Affairs
|
12 p.m. |
Lunch – Posters Available |
1 p.m. |
Pioneer Sponsor Address
- Primal Kaur, MD, MBA, VP, Global Development, Amgen
|
1:15 p.m. |
Panel: Business Development
- Moderators: Sarah Spencer (EcoR1)
- Jeannie Rojas, PhD, MBA - Sr. Director, Transactions, Worldwide Business Development, GSK
- Mark Dowling, PhD - Head of External Innovation - Immunology, Sanofi
- Ajay Narasimha, PhD - Head of Business Development, Immunology, Infectious Disease and Cardiometabolism, Genentech
-
- Nina Patel, MD - Director, Clinical Program Leader, Boehringer Ingelheim Adjunct Associate Professor of Medicine, Columbia University WOC Physician, Bronx VA Medical Center
|
2 p.m. |
Showcase Four: Technology Innovators: Devices, Digital, AI and More
- Albus Health - Mikesh Udani, MSc, Founder and CEO
- CSA Medical – Wendelin Maners, President and CEO
- DevPro Biopharma – Colin Reisner, MD, ATSF – Founder and CEO
- myBiometry – Bryan Nolan, Founder and CEO
- Synapse Biomedical – Raymond Onders, MD, Founder
- VisionHealth GMBH – Sabine Haeussermann, PhD, Founder and CEO
|
2:30 p.m. |
Networking Break - Posters Available |
3 p.m. |
Showcase Five: Fibrosis Innovators
- Fibronox – Louise Hecker, PhD, Chief Science Officer
- Halo Biosciences, Inc. – Anissa Kalinowski, MBA, MSc, Co-Founder and CEO
- Haya Therapeutics – James Karras, PhD, VP of Translational Sciences
- Tianali Biotech, LTD – Alistair G. Stewart, PhD, Chief Science Officer
|
3:30 p.m. |
RIS Featured Success Stories
- Moderator: David Morris, MD – President, Therapeutics and Technology, Valo Health
- Roberto Bellini, Managing Director BSQUARED Capital
|
3:45 p.m. |
Panel: Revisiting the Pumonary Functions Test
- Moderator: Craig Conoscenti, MD, ATSF - Avalyn Pharma, Inc.
- Amy Olson, MD, MSPH – Executive Director, Medical Affairs Strategy Team Lead, Boehringer Ingelheim Pharmaceuticals, Inc.
- Toby Maher, MBBS, MSC, PhD – Professor of Clinical Medicine, Keck School of Medicine, University of Southern California
- Helen Venn – Strategic Projects Director, Vitalograph
- Todd Austin – Executive Vice President, Global Business Development and Strategy, MGC Diagnostics
|
4:30 p.m. |
Closing Remarks and Sponsor Recognition
- Sarah Spencer (EcoR1) and Tim Watkins (Gilead Sciences)
|
4:45 p.m. |
Networking Reception – Posters Available |
6 p.m. |
Adjourn |